Advertisement

Is Organigram Stock a Buy?

Is Organigram Stock a Buy?

Retail cannabis sales in Canada have rebounded from a brief dip in February, but Organigram (NASDAQ: OGI) stock hasn't followed. Organigram might look like a bargain at its depressed price, but there's a chance the company will disappoint investors again before the end of the month. Organigram recently postponed its fiscal third-quarter earnings report until Jul. 21, 2020, but still provided a disappointing snapshot of the top line figures.